Oulu Research Group of Advanced Surgical Technologies and Physics - ORGASTP, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Neurocenter, Oulu University Hospital, Oulu, Finland.
Neurosurgery. 2023 May 1;92(5):1058-1065. doi: 10.1227/neu.0000000000002292. Epub 2022 Dec 30.
The development of diffusion tensor imaging and tractography has raised increasing interest in the functional targeting of deep brain stimulation of the subthalamic nucleus (STN) in Parkinson disease.
To study, using deterministic tractography, the functional subdivisions of the STN and hyperdirect white matter connections located between the STN and the medial frontal cortex, especially the presupplementary motor area (preSMA), SMA, primary motor area (M1), and dorsolateral premotor cortex, and to study retrospectively whether this information correlates with clinical outcome.
Twenty-two patients with Parkinson disease who underwent STN deep brain stimulation were analyzed. Using 3 T MR images, the medial frontal cortex was manually segmented into preSMA, SMA, M1, and dorsolateral premotor cortex, which were then used to determine the functional subdivisions of the lateral border of the STN. The intersectional quantities of the volume of activated tissue (VAT) and the hyperdirect white matter connections were calculated. The results were combined with clinical data including unilateral 12-month postoperative motor outcome and levodopa equivalent daily dose.
Stimulated clusters of the STN were connected mostly to the cortical SMA and preSMA regions. Patients with primarily preSMA cluster stimulation (presmaVAT% ≥ 50%) had good responses to the treatment with unilateral motor improvement over 40% and levodopa equivalent daily dose reduction over 60%. Larger VAT was not found to correlate with better patient outcomes.
Our study is the first to suggest that stimulating, predominantly, the STN cluster where preSMA hyperdirect pathways are located, could be predictive of more consistent treatment results.
弥散张量成像和束路追踪技术的发展提高了人们对深部脑刺激(subthalamic nucleus, STN)治疗帕金森病(subthalamic nucleus, STN)的功能定位的兴趣。
使用确定性束路追踪技术研究 STN 的功能亚区以及位于 STN 和内侧前额叶皮质之间的直接超投射白质连接,特别是辅助运动区(presupplementary motor area, preSMA)、运动前区(supplementary motor area, SMA)、初级运动区(primary motor area, M1)和背外侧运动前皮质,并回顾性研究这些信息是否与临床结果相关。
分析了 22 例接受 STN 深部脑刺激的帕金森病患者。使用 3 T MR 图像,手动将内侧前额叶皮质分割成 preSMA、SMA、M1 和背外侧运动前皮质,然后使用这些皮质来确定 STN 外侧边界的功能亚区。计算激活组织体积(VAT)和直接超投射白质连接的交叉量。将结果与包括单侧术后 12 个月运动结局和左旋多巴等效日剂量在内的临床数据相结合。
STN 刺激簇主要与皮质 SMA 和 preSMA 区域相连。主要刺激 preSMA 簇的患者(presmaVAT%≥50%)对单侧运动改善超过 40%和左旋多巴等效日剂量减少超过 60%的治疗反应良好。较大的 VAT 并未发现与更好的患者结局相关。
我们的研究首次表明,刺激主要位于 preSMA 直接投射通路的 STN 簇,可能是更一致的治疗效果的预测因素。